RVTY:NYSERevvity, Inc. Analysis

Revvity (RVTY) is trading around $100.55, just above its 20‑day SMA of $99.40 and comfortably above the 50‑day ($94.84) and 200‑day ($95.37) averages, indicating a short‑term price cushion but a neutral overall trend (RSI 54). The MACD shows a bearish divergence with the histogram at –0.26, volume is decreasing, and the stock sits midway between a support level near $92.97 and resistance around $106.21, suggesting limited upside in the near term. Valuation metrics are stretched: a trailing P/E of 48× dwarfs the industry average of 24×, while the DCF‑derived fair value of $58.73 is far below the current price, implying the stock is overvalued by roughly 70%.
Fundamentally, Revvity delivered a 7% YoY revenue increase to $711 M in Q1 and posted non‑GAAP EPS of $1.04, beating consensus, yet its full‑year revenue guidance fell short of analyst expectations. The company maintains a modest dividend of 0.28% with a low payout ratio (~13%), strong operating cash flow ($570 M) and free cash flow ($509 M), but carries a high debt load (Debt/Equity >46) and a beta above 1.4, reflecting elevated market sensitivity. The blend of growth‑oriented earnings outlook (forward EPS $5.82, forward P/E 17×) and high valuation suggests a cautious approach pending a price correction.